Anxiety and depression in patients with advanced macular degeneration: current perspectives.

Authors

Verena R Cimarolli, Research Institute on Aging, Jewish Home Lifecare
Robin J Casten, Department of Psychiatry and Human Behavior, Sidney Kimmel Medical College at Thomas Jefferson UniversityFollow
Barry W. Rovner, Department of Neurology, Sidney Kimmel Medical College at Thomas Jefferson University; Department of Psychiatry, Sidney Kimmel Medical College at Thomas Jefferson University; Department of Ophthalmology, Sidney Kimmel Medical College at Thomas Jefferson UniversityFollow
Vera Heyl, Institute of Special Education, University of Education, Heidelberg, Germany
Silvia Sörensen, Warner School of Education and Human Development, University of Rochester; Department of Ophthalmology, Flaum Eye Institute, University of Rochester School of Medicine and Dentistry
Amy Horowitz, Graduate School of Social Service, Fordham University

Document Type

Article

Publication Date

12-30-2015

Comments

This article has been peer reviewed. It was published in: Clinical Ophthalmology.

Volume 10, 2016, Pages 55-63.

The published version is available at DOI: 10.2147/OPTH.S80489

Copyright © 2016 Cimarolli et al.

This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Abstract

Age-related macular degeneration (AMD) - despite advances in prevention and medical treatment options - remains prevalent among older adults, often resulting in functional losses that negatively affect the mental health of older adults. In particular, the prevalence of both anxiety and depression in patients with AMD is high. Along with medical treatment options, low vision rehabilitation and AMD-specific behavioral and self-management programs have been developed and have demonstrated effectiveness in improving the mental health of AMD patients. This article reviews the prevalence of anxiety and depression in patients with advanced AMD, discusses potential mechanisms accounting for the development of depression and anxiety in AMD patients, presents the state-of the-art of available interventions for addressing anxiety and depression in AMD patients, and delineates recommendations for eye care professionals regarding how to screen for these two prevalent mental health problems and how to facilitate appropriate treatment for patients with AMD.

Recommended Citation

Cimarolli, Verena R; Casten, Robin J; Rovner, Barry W.; Heyl, Vera; Sörensen, Silvia; and Horowitz, Amy, "Anxiety and depression in patients with advanced macular degeneration: current perspectives." (2015). Department of Medicine Faculty Papers. Paper 147.
https://jdc.jefferson.edu/medfp/147

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 3.0 License

PubMed ID

26766899